Jonathan Burdon
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Microbiology top 10%
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 8
-
- Protease and Inhibitor Mechanisms 9
- Co-authors
- Niels Seersholm (7 shared papers)Eeva Piitulainen (7 shared papers)Kenneth R. Chapman (8 shared papers)Berend C. Stoel (2 shared papers)John B. Carlin (1 shared paper)James Stocks (7 shared papers)Noel G. McElvaney (7 shared papers)Robert A. Sandhaus (7 shared papers)
- Journals
- The Medical Journal of Australia (7 papers)Respirology (6 papers)Thorax (3 papers)CHEST Journal (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Jonathan Burdon
55 papers receiving 1.1k citations
Jonathan Burdon's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 282
- Microbiology 11
- Pulmonary and Respiratory Medicine 382
- Chemical Health and Safety 8
- Dermatology 82
Countries citing papers authored by Jonathan Burdon
This map shows the geographic impact of Jonathan Burdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Burdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Burdon more than expected).
Fields of papers citing papers by Jonathan Burdon
This network shows the impact of papers produced by Jonathan Burdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Burdon. The network helps show where Jonathan Burdon may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Burdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 342 |
| 2 | 1994 | 131 | |
| 3 | 2012 | 70 | |
| 4 | 1978 | 65 | |
| 5 | 2018 | 51 | |
| 6 | 1996 | 45 | |
| 7 | 2001 | 36 | |
| 8 | 1991 | 34 | |
| 9 | 1996 | 28 | |
| 10 | 1979 | 27 | |
| 11 | 1975 | 26 | |
| 12 | 1990 | 24 | |
| 13 | 1985 | 24 | |
| 14 | 1977 | 23 | |
| 15 | Aerotoxic Syndrome: A New Occupational Disease? | 2017 | 23 |
| 16 | 1988 | 20 | |
| 17 | 1997 | 19 | |
| 18 | 2023 | 18 | |
| 19 | 1988 | 18 | |
| 20 | 2010 | 17 |
About Jonathan Burdon
Jonathan Burdon is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology, Molecular Biology and Surgery, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Occupational exposure and asthma (4 papers), Peptidase Inhibition and Analysis (4 papers), Asthma and respiratory diseases (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Lung Cancer Research Studies (3 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Cancer Research (282 citations), Microbiology (11 citations), Pulmonary and Respiratory Medicine (382 citations), Chemical Health and Safety (8 citations) and Dermatology (82 citations). Jonathan Burdon has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Niels Seersholm, Eeva Piitulainen, Kenneth R. Chapman, Berend C. Stoel, John B. Carlin, James Stocks, Noel G. McElvaney, Robert A. Sandhaus, Daniel Czarny and Jonathan M. Edelman. Their work appears in journals such as The Medical Journal of Australia, Respirology, Thorax, CHEST Journal and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.